Streetbeat News

Regulatory

VNDA

Vanda Pharmaceuticals has been granted FDA Orphan Drug Designation for the treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S). This designation provides various benefits, including tax credits and market exclusivity.

Portfolio Pulse from Charles Gross

May 31, 2023 | 11:06 pm

PFE

Pfizer announced that the FDA has approved ABRYSVO, a vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals aged 60 and older. The approval is based on data from the pivotal Phase 3 clinical trial RENOIR.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 9:52 pm

BTCUSD

The European Union has enacted the Markets in Crypto Assets (MiCA) regulation, positioning the bloc as a pioneer in cryptocurrency regulation. The MiCA regulation is expected to come into effect in the coming weeks and will grant crypto exchanges and wallet providers a license to operate across the 27-member bloc.

Portfolio Pulse from Murtuza Merchant

May 31, 2023 | 8:58 pm

CRON

Cronos Group plans to streamline its operating structure by exiting its U.S. hemp-derived CBD operations by the end of Q2 2023. The decision aims to improve cash flow and position the company to enter the U.S. THC market when regulatory conditions change.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 8:51 pm

HOOK

HOOKIPA Pharma announced preliminary Phase 2 data on HB-200 in combination with pembrolizumab for treating HPV16+ head and neck cancers. The results showed promising anti-tumor activity and a favorable safety profile.

Portfolio Pulse from Bill Haddad

May 31, 2023 | 8:47 pm

IFBD

Infobird Co., Ltd has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the exchange.

Portfolio Pulse from Happy Mohamed

May 31, 2023 | 8:32 pm

SPY

The U.S. House of Representatives has approved a measure to begin a one-hour debate on the debt ceiling bill, with a vote on passage expected in the evening.

Portfolio Pulse from Happy Mohamed

May 31, 2023 | 8:32 pm

HST

Host Hotels & Resorts has filed a prospectus supplement for a common stock offering from time to time of up to $600 million, according to an SEC filing.

Portfolio Pulse from Happy Mohamed

May 31, 2023 | 8:31 pm

MBSC

M3-Brigade Acquisition III Corp. (MBSC) has received a notice from the NYSE regarding a delayed Form 10-Q filing.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 8:27 pm

AVHI

Achari Ventures Holdings Corp. I (NASDAQ:AVHI) received a deficiency letter from NASDAQ for not complying with Listing Rule 5250(c)(1) due to a delay in filing its Form 10-Q for the period ending March 31, 2023. The company has since filed the Form 10-Q.

Portfolio Pulse from Happy Mohamed

May 31, 2023 | 8:19 pm